MX2012008871A - A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation. - Google Patents

A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation.

Info

Publication number
MX2012008871A
MX2012008871A MX2012008871A MX2012008871A MX2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A MX 2012008871 A MX2012008871 A MX 2012008871A
Authority
MX
Mexico
Prior art keywords
acne
adapalene
post
decrease
treatment
Prior art date
Application number
MX2012008871A
Other languages
Spanish (es)
Inventor
Pascale Soto
Jean-Charles Dhuin
Nabil Kerrouche
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2012008871A publication Critical patent/MX2012008871A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a dermatological composition comprising a combination of Adapalene and benzoyl peroxide which is intended for the treatment of acne in non-Caucasian population with decrease of post-inflammatory hyperpigmentation, keloid scarring and acne hyperpigmented macules and cystic lesions.
MX2012008871A 2010-02-09 2011-02-03 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation. MX2012008871A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30258210P 2010-02-09 2010-02-09
PCT/EP2011/051580 WO2011098391A1 (en) 2010-02-09 2011-02-03 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation

Publications (1)

Publication Number Publication Date
MX2012008871A true MX2012008871A (en) 2012-08-31

Family

ID=43734249

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008871A MX2012008871A (en) 2010-02-09 2011-02-03 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation.

Country Status (7)

Country Link
US (1) US20130131177A1 (en)
EP (1) EP2533776A1 (en)
JP (1) JP2013518920A (en)
KR (1) KR20120118064A (en)
BR (1) BR112012019827A2 (en)
MX (1) MX2012008871A (en)
WO (1) WO2011098391A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027984A1 (en) 2006-08-29 2008-03-06 Isolagen Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
FR2910321B1 (en) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
FR2910320B1 (en) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
EP2563357B1 (en) * 2010-04-29 2018-10-17 Galderma Research & Development Adapalene 0.3% for use in a method for treating scars
WO2013134248A2 (en) * 2012-03-07 2013-09-12 Fibrocell Technologies, Inc. Topical dermal formulations and methods of personalized treatment of skin
CA2870690A1 (en) * 2012-05-25 2013-11-28 Galderma Research & Development Treatment of preadolescent moderate acne vulgaris
WO2015150332A1 (en) * 2014-04-01 2015-10-08 Galderma Research & Development Combination of adapalene and benzoyl peroxide for treating acne scars
MX2018002176A (en) 2015-08-20 2018-06-15 Sol Gel Tech Ltd Compositions for topical application comprising benzoyl peroxide and adapalene.
WO2023068233A1 (en) * 2021-10-18 2023-04-27 マルホ株式会社 Activity inhibitor and/or production suppressant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833841B1 (en) 2001-12-21 2005-07-22 Galderma Res & Dev GEL COMPRISING AT LEAST ONE RETINOID AND BENZOYL PEROXIDE
FR2837101B1 (en) 2002-03-12 2004-07-02 Galderma Res & Dev USE OF 6- [1-ADAMANTYL) -4-METHOXYPHENYL] -2- NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
FR2903603B1 (en) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc COMBINATION OF ADAPALENE AND BENZOLEO PEROXIDE IN THE TREATMENT OF ACNE
US8080537B2 (en) * 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
US8853275B2 (en) * 2008-05-16 2014-10-07 Galderma Research & Development Concurrent therapy regime/regimen for the treatment of acne related diseases

Also Published As

Publication number Publication date
WO2011098391A1 (en) 2011-08-18
US20130131177A1 (en) 2013-05-23
BR112012019827A2 (en) 2016-05-17
KR20120118064A (en) 2012-10-25
JP2013518920A (en) 2013-05-23
EP2533776A1 (en) 2012-12-19

Similar Documents

Publication Publication Date Title
MX2012008871A (en) A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation.
LT2450035T (en) Combination of adapalene and benzoyl peroxide for treating acne lesions
EP2294669B8 (en) Direct current power combiner
EP2621374A4 (en) Power assisted lipoplasty
PT2332520T (en) Lactobacillus paracasei for treating age spots and / or melasma
PL2464617T3 (en) Method and system for providing a hydrocarbon-based energy source using a portion of renewably produced methanol and a portion of methanol that is produced by means of direct oxidation, partial oxidation, or reforming
IL205905A0 (en) Stable dispersions of single and multiple graphene layers in solution
EP2297847A4 (en) Rf power amplifiers with linearization
IL223032A0 (en) Ultra-high efficiency switching power inverter and power amplifier
EP2329002A4 (en) Concentrated hydrogen peroxide disinfecting solutions
EP2654696A4 (en) Enzymatic peracid generation for use in hair care products
TWI341078B (en) Cascode-cascade doherty power amplifier
EP2654695B8 (en) Enzymatic peracid generation for use in oral care products
GB201109529D0 (en) Improved electrocatalyst for hydrogen peroxide cathodes and electrolating process
EP2266214A4 (en) Reduction of out-of-band emitted power
EP2303812A4 (en) Combined carbon dioxide and oxygen process for ethylbenzene dehydrogenation to styrene
HK1178468A1 (en) Bio-terrorism counteraction using ozone and hydrogen peroxide
GB2470693B (en) Processor having reduced power consumption
HK1255668A1 (en) Composition comprising a diindolylmethane and a retinoid to treat a skin condition
EP2465191A4 (en) Low power switch mode power supply
WO2011137456A9 (en) Methods and mechanisms involving hyperpigmentation particularly for african american skin
EP2396069A4 (en) Endoscopic forceps with removable handle
EP2408480A4 (en) Oct guided tissue ablation
PL2114392T3 (en) Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
EP2645861B8 (en) Effervescent composition for improved carbon dioxide generation in insect monitor devices

Legal Events

Date Code Title Description
HH Correction or change in general